LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma | MicrobiomeTrials← Back to trialsNCT06623461
LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-04-07Est. Completion: 2028-12-31
Enrollment target: 128 participants Locations- BCCA - Abbotsford, Abbotsford British Columbia, British Columbia, Canada
- BCCA - Surrey, Surrey, British Columbia, Canada
- BCCA - Vancouver, Vancouver, British Columbia, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
- London Health Sciences Centre Research Inc., London, Ontario, Canada
- Stronach Regional Health Centre at Southlake, Newmarket, Ontario, Canada
- Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
- Odette Cancer Centre, Toronto, Ontario, Canada
- University Health Network, Toronto, Ontario, Canada
- Centre Integre de Sante et de Services Sociaux, Greenfield Park, Quebec, Canada
- CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada
- The Jewish General Hospital, Montreal, Quebec, Canada
- Hotel-Dieu de Quebec, Québec, Quebec, Canada
- Centre hospitalier regional de Trois-Rivieres, Trois-Rivières, Quebec, Canada
Other microbiome trials you might be interested in
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IIB Cutaneous Melanoma AJCC v8Clinical Stage IIC Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Esophageal CarcinomaGastroesophageal Junction AdenocarcinomaHepatocellular CarcinomaLocally Advanced Urothelial Carcinoma
Lung Non-Small Cell Carcinoma
Malignant Solid Neoplasm
Metastatic Colorectal Carcinoma
Metastatic Cutaneous Melanoma
Metastatic Esophageal Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell Carcinoma
Metastatic Urothelial Carcinoma
Recurrent Esophageal Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma
Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Colorectal Cancer AJCC v8
Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
Stage IV Renal Cell Cancer AJCC v8
Unresectable Cutaneous Melanoma
Unresectable Esophageal Squamous Cell Carcinoma
Urothelial Carcinoma
Unresectable Urothelial Carcinoma
This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setti…
Jacksonville, United StatesEst. completion Dec 31, 2026
Melanoma Stage IV
This study looks at whether the bacteria naturally present in urine (the "urinary microbiome") can help doctors better u…
Gratwein, AustriaEst. completion May 2028
MelanomaLi-Fraumeni SyndromePulmonary BlastomaChordomaCongenital Bone Marrow Failure SyndromesCostello SyndromeFanconi AnemiaCFC Syndrome (CFCS)Legius SyndromeRASopathies
Background:
Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer…
Rockville, United StatesEst. completion Jan 1, 2035